Sort by
Refine Your Search
-
at the interface between computational design and in vitro experiments, the team has developed multiple in silico and in vitro methods to design novel antibodies and nanobodies as therapeutic agents and research
-
. You'll be instrumental in transforming our existing offerings, ensuring they align with our strategic priorities and foster a culture of continuous growth and excellence. As our Head of Learning and Talent
-
. You’ll work closely with colleagues across ICT, the Digital Campus programme, and Imperial-wide to ensure alignment on accountability for cross-divisional data and systems, rationalising and integrating
-
newsletters to highlight the support and opportunities aligned to CATO. You will be working closely with senior Research Leads and others at Imperial and in the AHSC partner organisations. This is a great
-
sequencing and other omic data from APSN and tumours specimens, you will identify markers/pathways that predict which APSN become malignant and those that distinguish good-prognosis from poor-prognosis tumours
-
collaborators during the project. You will get to work on this high-profile, ground-breaking project and make use state of the art techniques and technologies (e.g. chromosome synthesis, nanopore sequencing
-
also robust across noisy, incomplete, or diverse input modalities. The research will explore the alignment and fusion of heterogeneous modalities through techniques and special emphasis will be placed
-
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities mentioned above. We reserve the right to close
-
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities mentioned above. We reserve the right to close
-
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities mentioned above. We reserve the right to close